ERC1 anticorps (AA 721-1116)

N° du produit ABIN7876644

L’anticorps anti-ERC1 Polyclonal Lapin est utilisé pour la détection de ERC1 dans des échantillons de Humain, Souris et Rat. Il a été validé pour WB, ELISA, IP, IF, FACS et ICC.

Aperçu rapide pour ERC1 anticorps (AA 721-1116) (ABIN7876644)

Antigène: ERC1 (ELKS/RAB6-Interacting/CAST Family Member 1 (ERC1))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ERC1 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunoprecipitation (IP), Immunofluorescence (IF), Flow Cytometry (FACS), Immunocytochemistry (ICC)

Détail du produit anti-ERC1 anticorps

Épitope: AA 721-1116

Fonction: ERC1 Antibody / ELKS/RAB6-interacting/CAST family member 1

Purification: Immunogen affinity purified

Immunogène: E.coli-derived human ERC1 recombinant protein (Position: H721-S1116) was used as the immunogen for the ERC1 antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the ERC1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the ERC1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur ERC1

Antigène: ERC1 (ELKS/RAB6-Interacting/CAST Family Member 1 (ERC1))

Autre désignation: ERC1

Sujet: ERC1 antibody detects ELKS/RAB6-interacting/CAST family member 1, encoded by the ERC1 gene. ERC1 is a scaffolding protein localized at presynaptic active zones, where it organizes signaling complexes and regulates neurotransmitter release. ERC1 antibody provides researchers with a useful reagent to study synaptic transmission, active zone assembly, and neuronal signaling.

ERC1 contains coiled-coil domains that mediate interactions with multiple active zone proteins, including RIM, Munc13, and Bassoon. Research using ERC1 antibody has shown that it anchors voltage-gated calcium channels and synaptic vesicle machinery at release sites. This organization ensures efficient neurotransmitter release in response to action potentials. Without ERC1, active zones are structurally disorganized, impairing synaptic transmission.

Studies with ERC1 antibody have demonstrated that it also participates in vesicle trafficking. ERC1 interacts with Rab6 and regulates transport of vesicle precursors to synaptic terminals. This trafficking function integrates with its scaffolding role, ensuring proper delivery and assembly of presynaptic components. These findings highlight ERC1 as a central organizer of synaptic release machinery.

Dysregulation of ERC1 has been associated with neurological disease. Research using ERC1 antibody has linked altered expression to autism spectrum disorders, epilepsy, and schizophrenia. By disrupting active zone architecture, mutations or expression changes in ERC1 impair synaptic connectivity and neuronal communication. ERC1 fusions with other genes have also been identified in cancers, linking synaptic scaffolding proteins to oncogenesis.

ERC1 antibody is commonly used in western blotting, immunohistochemistry, and immunofluorescence. Western blotting quantifies ERC1 expression in neuronal and non-neuronal tissues, immunohistochemistry identifies localization in brain tissue, and immunofluorescence highlights colocalization with active zone proteins. These applications make ERC1 antibody valuable in neuroscience and disease research.

By supplying validated ERC1 antibody reagents, NSJ Bioreagents supports studies into synaptic organization, neurotransmitter release, and disease. Detection of ELKS/RAB6-interacting/CAST family member 1 provides researchers with insight into how scaffolding proteins regulate synaptic architecture.

UniProt: Q8IUD2

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2